Impellam Group plc (IPEL):企業の財務・戦略的SWOT分析

◆英語タイトル:Impellam Group plc (IPEL) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C10726
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Impellam Group plc (IPEL) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Impellam Group plc (Impellam) is a provider of specialist staff and managed services. The company offers multi-disciplinary recruitment and supply management services; and recruitment services for permanent, temporary, contract and fixed price work. It offers recruitment process outsourcing services; and specialist staffing services in the healthcare, social care, legal, engineering, catering, driving, office, industrial, science, clinical, education, finance and accountancy, sales, information technology, aviation, and cleaning sectors. It also offers employer branded recruitment, business process outsourcing, and payroll services, as well as statement of work solutions and strategic consultancy and insight across North America, Europe, and Asia Pacific. Impellam is headquartered in Luton, Bedfordshire, the UK.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Impellam Group plc – Key Facts 6
Impellam Group plc – Key Employees 7
Impellam Group plc – Key Employee Biographies 8
Impellam Group plc – Major Products and Services 9
Impellam Group plc – History 10
Impellam Group plc – Company Statement 11
Impellam Group plc – Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Joint Venture 13
Section 2 – Company Analysis 14
Company Overview 14
Impellam Group plc – Business Description 15
Business Segment: Managed Services 15
Overview 15
Performance 15
Business Segment: Specialist Staffing 15
Overview 15
Performance 15
Geographical Segment: Asia Pacific 15
Performance 15
Geographical Segment: Europe 15
Performance 15
Geographical Segment: North America 16
Performance 16
Geographical Segment: United Kingdom 16
Performance 16
Impellam Group plc – Corporate Strategy 17
Impellam Group plc – SWOT Analysis 18
SWOT Analysis – Overview 18
Impellam Group plc – Strengths 18
Impellam Group plc – Weaknesses 19
Impellam Group plc – Opportunities 20
Impellam Group plc – Threats 21
Impellam Group plc – Key Competitors 22
Section 3 – Company Financial Ratios 23
Financial Ratios – Capital Market Ratios 23
Financial Ratios – Annual Ratios 24
Performance Chart 27
Financial Performance 27
Financial Ratios – Interim Ratios 28
Financial Ratios – Ratio Charts 29
Section 4 – Appendix 30
Methodology 30
Ratio Definitions 30
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Impellam Group plc, Key Facts 6
Impellam Group plc, Key Employees 7
Impellam Group plc, Key Employee Biographies 8
Impellam Group plc, Major Products and Services 9
Impellam Group plc, History 10
Impellam Group plc, Subsidiaries 12
Impellam Group plc, Joint Venture 13
Impellam Group plc, Key Competitors 22
Impellam Group plc, Ratios based on current share price 23
Impellam Group plc, Annual Ratios 24
Impellam Group plc, Annual Ratios (Cont...1) 25
Impellam Group plc, Annual Ratios (Cont...2) 26
Impellam Group plc, Interim Ratios 28
Currency Codes 30
Capital Market Ratios 30
Equity Ratios 31
Profitability Ratios 31
Cost Ratios 32
Liquidity Ratios 32
Leverage Ratios 33
Efficiency Ratios 33

List of Figures
Impellam Group plc, Performance Chart (2013 - 2017) 27
Impellam Group plc, Ratio Charts 29

★海外企業調査レポート[Impellam Group plc (IPEL):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Business Development Bank Of Canada:企業の戦略・SWOT・財務分析
    Business Development Bank Of Canada - Strategy, SWOT and Corporate Finance Report Summary Business Development Bank Of Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Shell Canada Ltd-石油・ガス分野:企業M&A・提携分析
    Summary Shell Canada Ltd (Shell Canada), a subsidiary of Royal Dutch Shell plc is an integrated oil and gas company that offers upstream and downstream services. The company's upstream services include markets and trades natural gas and power and exploration and extraction of natural gas. Its downst …
  • Xerium Technologies Inc:企業の戦略的SWOT分析
    Xerium Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • MedImmune LLC-製薬・医療分野:企業M&A・提携分析
    Summary MedImmune LLC (MedImmune), a subsidiary of AstraZeneca Plc, is a biotechnology company. It focuses on the research, development, manufacture and marketing of small molecules and biologics to address some of the major medical needs. The company develops therapeutic proteins, monoclonal antibo …
  • Ocean Power Technologies Inc (OPTT):電力:M&Aディール及び事業提携情報
    Summary Ocean Power Technologies, Inc. (OPT) is a provider of ocean energy solutions. The company harnesses the abundant wave power to draw out renewable energy; and commercializes ocean wave power conversion technology products. The company's PB3 PowerBuoy integrates patented technologies in hydrod …
  • Public Service Enterprise Group Inc (PEG)-エネルギー分野:企業M&A・提携分析
    Summary Public Service Enterprise Group Inc. (PSEG) is a diversified energy holding company that generates, transmits and distributes electricity, and gas. It supplies electricity from its nuclear, fossil and renewable energy assets as part of its wholesale energy activities. The company sells elect …
  • ViroGates AS:医療機器:M&Aディール及び事業提携情報
    Summary ViroGates AS (ViroGates) is a meditech company that offers prognostic products. The company develops a prognostic biomarker to make the suPAR test presented as a commercially available test. Its products comprise measures suPAR, quick triage and ELISA. ViroGates’ suparnostic products offer a …
  • General Electric Co (GE)-エネルギー分野:企業M&A・提携分析
    Summary General Electric Company (GE) is a digital industrial company. It offers a range of industrial, infrastructure and financial services globally. The company offers a range of products and services from aircraft engines, power generation and oil and gas production equipment to medical imaging, …
  • Guy’s and St Thomas’ NHS Foundation Trust:企業の戦略的SWOT分析
    Guy's and St Thomas' NHS Foundation Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Nezavisni operator sustava u Bosni i Hercegovini:企業の戦略的SWOT分析
    Nezavisni operator sustava u Bosni i Hercegovini - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competit …
  • Vietnam Electricity:企業の戦略的SWOT分析
    Vietnam Electricity - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • United States Endoscopy Group Inc:企業の戦略的SWOT分析
    United States Endoscopy Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Electricity Supply Board:電力:M&Aディール及び事業提携情報
    Summary Electricity Supply Board (ESB) owned by Irish Government, is a diversified and vertically integrated utility that generates, transmits, and distributes and supplies electricity and gas. The company builds, owns and maintains transmission and distribution networks. It offers meter reading, an …
  • Immunicum AB (IMMU):企業の財務・戦略的SWOT分析
    Summary Immunicum AB (Immunicum) is a biopharmaceutical company that focuses on the development of immuno-oncology therapies for the treatment of solid tumors. The company’s lead development candidate, ilixadencel is in clinical trials for the treatment a range of solid tumors including hepatic cell …
  • International Coffee & Tea, LLC:企業の戦略・SWOT・財務情報
    International Coffee & Tea, LLC - Strategy, SWOT and Corporate Finance Report Summary International Coffee & Tea, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Amcor Ltd:戦略・SWOT・企業財務分析
    Amcor Ltd - Strategy, SWOT and Corporate Finance Report Summary Amcor Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Omnicom Group, Inc.:企業の戦略・SWOT・財務分析
    Omnicom Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Omnicom Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Highmark Inc-製薬・医療分野:企業M&A・提携分析
    Summary Highmark Inc (Highmark), a subsidiary of Highmark Health, is a provider of healthcare insurance solutions. The company underwrites various indemnities and offers healthcare insurance products to individuals, families, groups, companies and federal employees. In addition, the company provides …
  • China General Plastics Corp (1305):企業の財務・戦略的SWOT分析
    Summary China General Plastics Corp (CGPC), a subsidiary of USI Group is a chemical company that manufactures PVC resins. The company's products include poly vinyl chloride resins, raw materials, vinyl films, films and sheet products, construction products, leather products, and house ware products. …
  • Thar Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Thar Pharmaceuticals Inc (Thar Pharma), a subsidiary of Grunenthal GmbH is a healthcare solution provider that concentrates on transforming intravenous (IV) drugs into oral drugs for existing and new indications. The company’s lead product T121, an oral form of IV only zoledronic acid, is de …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆